| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytomx Therapeutics, Inc. (CTMX) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. CTMX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 987.9K | $3.90M | - | |
| Other | 650.0K | $2.56M | - | |
| CFO | 78.3K | $308.7K | - | |
| Other | 43.8K | $172.6K | - | |
| Dir | 38.0K | $149.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2018 | McCarthy Sean A.69 | President And CEO | Sale+OE | 13,052 | $21.86 | $285,342.82 | -13.7% | |
| Aug 1, 2018 | Ray Debanjan | Chief Financial Officer | Sale+OE | 3,000 | $26.05 | $78,150.00 | -33.6% | |
| Jul 5, 2018 | McCarthy Sean A.69 | President And CEO | Sale+OE | 4,497 | $25.06 | $112,688.52 | -5.2% | |
| Jul 3, 2018 | McCarthy Sean A.69 | President And CEO | Sale+OE | 2,028 | $25.09 | $50,880.49 | -2.4% | |
| Jul 2, 2018 | Ray Debanjan | Chief Financial Officer | Sale+OE | 3,000 | $22.56 | $67,680.00 | -33.6% | |
| Jul 2, 2018 | McCarthy Sean A.69 | President And CEO | Sale+OE | 13,052 | $23.42 | $305,707.86 | -13.7% | |
| Jun 1, 2018 | Ray Debanjan | Chief Financial Officer | Sale+OE | 3,000 | $25.93 | $77,793.00 | -33.6% | |
| May 1, 2018 | McCarthy Sean A.69 | President And CEO | Sale+OE | 19,578 | $26.55 | $519,743.04 | -80.8% | |
| May 1, 2018 | Ray Debanjan | Chief Financial Officer | Sale+OE | 3,000 | $26.52 | $79,562.10 | -38.8% | |
| Apr 2, 2018 | Ray Debanjan | Chief Financial Officer | Sale+OE | 3,000 | $28.12 | $84,360.00 | -38.8% |